Mutant Protein May Change Treatment Plans for Prostate Cancer
1/10/2019
Prostate cancer is the most common non-skin cancer in American men and remains a significant health risk. Scientists at Southern Research in Birmingham are studying a mutated protein that could hold the key to both development and treatment of this disease and possibly make the cancer more susceptible to radiation treatment. Click here learn more.